First-Generation Radiolabeled Cyclic Peptides for Molecular Imaging of Platelet-Derived Growth Factor Receptor α
The researchers investigated cyclic peptides targeting PDGFRα, using VICA™ for label-free binding assessment within the broader experimental program. Its contribution was the binding measurement across candidate cyclic peptides; the downstream radiotracer imaging work used orthogonal methods.
Study Context & Follow-Up
For peptide and antibody candidate ranking prior to labeling or in vivo studies, explore our Pilot Program or contact research@pavonis.ai.